See more : First IC Corporation (FIEB) Income Statement Analysis – Financial Results
Complete financial analysis of Celestica Inc. (CLS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Celestica Inc., a leading company in the Hardware, Equipment & Parts industry within the Technology sector.
You may be interested
- Conduit Pharmaceuticals Inc. (CDT) Income Statement Analysis – Financial Results
- Ortin Laboratories Limited (ORTINLAABS.BO) Income Statement Analysis – Financial Results
- LENZ Therapeutics, Inc. (LENZ) Income Statement Analysis – Financial Results
- Synopex Inc. (025320.KQ) Income Statement Analysis – Financial Results
- DMCC Speciality Chemicals Limited (DMCC.BO) Income Statement Analysis – Financial Results
Celestica Inc. (CLS)
About Celestica Inc.
Celestica Inc. provides hardware platform and supply chain solutions in North America, Europe, and Asia. It operates through two segments, Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, engineering, supply chain management, new product introduction, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services. It also provides enterprise-level data communications and information processing infrastructure products, such as routers, switches, data center interconnects, edge solutions, servers, and storage-related products; capacitors, microprocessors, resistors, and memory modules; and power inverters, energy storage products, smart meters, and other electronic componentry products. The company serves aerospace and defense, industrial, energy, healthtech, capital equipment, original equipment manufacturers, cloud-based, and other service providers, including hyperscalers, and other companies in a range of industries. Celestica Inc. was incorporated in 1994 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.96B | 7.25B | 5.63B | 5.75B | 5.89B | 6.63B | 6.11B | 6.02B | 5.64B | 5.63B | 5.80B | 6.51B | 7.21B | 6.53B | 6.09B | 7.68B | 8.07B | 8.81B | 8.47B | 8.84B | 6.74B | 8.27B | 10.00B | 9.75B | 5.30B | 3.25B | 2.01B |
| Cost of Revenue | 7.18B | 6.61B | 5.15B | 5.31B | 5.50B | 6.20B | 5.69B | 5.59B | 5.25B | 5.23B | 5.41B | 6.07B | 6.72B | 6.08B | 5.66B | 7.15B | 7.65B | 8.36B | 7.99B | 8.43B | 6.47B | 7.72B | 9.29B | 9.06B | 4.84B | 2.98B | 1.85B |
| Gross Profit | 778.50M | 636.30M | 487.00M | 437.60M | 384.70M | 430.50M | 417.80M | 427.60M | 391.10M | 405.40M | 389.50M | 438.40M | 491.40M | 443.30M | 429.80M | 531.10M | 422.40M | 451.80M | 481.10M | 407.90M | 261.00M | 555.80M | 712.50M | 688.00M | 453.50M | 272.10M | 161.50M |
| Gross Profit Ratio | 9.78% | 8.78% | 8.64% | 7.61% | 6.53% | 6.49% | 6.84% | 7.11% | 6.94% | 7.20% | 6.72% | 6.74% | 6.81% | 6.79% | 7.05% | 6.92% | 5.23% | 5.13% | 5.68% | 4.61% | 3.88% | 6.72% | 7.12% | 7.05% | 8.56% | 8.37% | 8.05% |
| Research & Development | 60.90M | 46.30M | 38.40M | 29.90M | 28.40M | 28.80M | 26.20M | 24.90M | 23.20M | 19.70M | 17.40M | 15.20M | 13.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 245.10M | 230.70M | 227.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 279.60M | 279.90M | 245.10M | 230.70M | 227.30M | 219.00M | 203.20M | 211.10M | 207.50M | 210.30M | 222.30M | 237.00M | 253.40M | 250.20M | 244.50M | 303.80M | 295.10M | 285.60M | 296.90M | 331.60M | 249.80M | 298.50M | 341.40M | 326.05M | 202.20M | 130.60M | 81.60M |
| Other Expenses | 54.80M | 40.10M | 25.50M | 25.60M | 29.60M | 15.40M | 8.90M | 9.40M | 9.20M | 10.60M | 12.20M | 11.30M | 20.00M | 19.80M | -22.20M | 5.70M | 21.30M | 27.00M | 28.40M | 34.60M | 223.90M | 773.70M | 398.10M | 88.94M | 126.50M | 86.90M | 37.10M |
| Operating Expenses | 395.30M | 366.30M | 309.00M | 286.20M | 285.30M | 263.20M | 238.30M | 245.40M | 239.90M | 240.60M | 251.90M | 263.50M | 287.20M | 270.00M | 266.40M | 318.90M | 316.40M | 312.60M | 325.30M | 366.20M | 497.70M | 1.07B | 739.50M | 414.99M | 328.70M | 217.50M | 118.70M |
| Cost & Expenses | 7.58B | 6.98B | 5.46B | 5.60B | 5.79B | 6.47B | 5.93B | 5.83B | 5.49B | 5.47B | 5.66B | 6.33B | 7.01B | 6.35B | 5.93B | 7.47B | 7.96B | 8.67B | 8.32B | 8.80B | 6.97B | 8.79B | 10.03B | 9.48B | 5.17B | 3.19B | 1.96B |
| Interest Income | 0.00 | 59.70M | 31.70M | 37.70M | 49.50M | 0.00 | 0.00 | 14.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.30M | 57.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 76.60M | 59.70M | 31.70M | 37.70M | 49.50M | 24.40M | 10.10M | 10.00M | 6.30M | 3.10M | 2.90M | 3.50M | 5.40M | 6.50M | 300.00K | 15.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 160.40M | 139.06M | 125.19M | 131.29M | 138.55M | 84.56M | 79.25M | 74.69M | 68.30M | 68.70M | 71.70M | 81.70M | 77.20M | 87.80M | 100.40M | 109.20M | 130.80M | 134.20M | 152.70M | 207.70M | 222.10M | 311.00M | 319.50M | 212.50M | 126.50M | 86.90M | 37.10M |
| EBITDA | 543.60M | 263.30M | 167.70M | 127.90M | 149.30M | 106.30M | 227.60M | 248.60M | 183.70M | 196.40M | 209.30M | 256.50M | 281.40M | 261.10M | 317.30M | -476.74M | 236.80M | 273.40M | 308.50M | 249.40M | 160.50M | 472.10M | 292.50M | 485.51M | 251.30M | 141.50M | 93.01M |
| EBITDA Ratio | 6.83% | 5.72% | 5.35% | 4.80% | 3.88% | 3.85% | 4.19% | 4.52% | 3.89% | 4.15% | 3.61% | 3.94% | 3.90% | 4.00% | 5.21% | 4.19% | 3.53% | 5.52% | 5.28% | 9.88% | 2.39% | 5.97% | 5.88% | 5.14% | 4.93% | 6.39% | 4.30% |
| Operating Income | 383.20M | 263.30M | 167.70M | 127.90M | 93.30M | 106.30M | 142.50M | 156.70M | 115.40M | 127.70M | 133.60M | 115.40M | 204.20M | 173.30M | 207.50M | 212.20M | 105.90M | 138.30M | 155.20M | -115.10M | -236.70M | -537.50M | -49.80M | 273.01M | 124.80M | 54.60M | 42.80M |
| Operating Income Ratio | 4.81% | 3.63% | 2.98% | 2.23% | 1.58% | 1.60% | 2.33% | 2.60% | 2.05% | 2.27% | 2.30% | 1.77% | 2.83% | 2.66% | 3.41% | 2.76% | 1.31% | 1.57% | 1.83% | -1.30% | -3.51% | -6.50% | -0.50% | 2.80% | 2.36% | 1.68% | 2.13% |
| Total Other Income/Expenses | -76.60M | -59.70M | -31.70M | -37.70M | -49.50M | -24.40M | -10.10M | 2.30M | -6.30M | -3.10M | -2.90M | -62.90M | -2.60M | -53.90M | -147.10M | -937.10M | -98.80M | -274.40M | -180.70M | -486.80M | -77.00M | -307.90M | 7.90M | 2.88M | -20.30M | -105.10M | -47.50M |
| Income Before Tax | 306.60M | 203.60M | 136.00M | 90.20M | 99.80M | 81.90M | 132.40M | 161.00M | 109.10M | 124.60M | 130.70M | 111.90M | 198.80M | 102.60M | 60.40M | -715.50M | 7.10M | -136.10M | -25.50M | -601.90M | -232.70M | -536.40M | -41.90M | 275.89M | 104.50M | -50.50M | -4.70M |
| Income Before Tax Ratio | 3.85% | 2.81% | 2.41% | 1.57% | 1.69% | 1.23% | 2.17% | 2.68% | 1.93% | 2.21% | 2.25% | 1.72% | 2.76% | 1.57% | 0.99% | -9.32% | 0.09% | -1.54% | -0.30% | -6.81% | -3.45% | -6.48% | -0.42% | 2.83% | 1.97% | -1.55% | -0.23% |
| Income Tax Expense | 62.00M | 58.10M | 32.10M | 29.60M | 29.50M | -17.00M | 27.40M | 24.70M | 42.20M | 16.40M | 12.70M | -5.80M | 3.70M | 21.80M | 5.40M | 5.00M | 20.80M | 14.50M | 21.30M | 252.20M | 33.10M | -91.20M | -2.10M | 69.21M | 36.10M | -2.00M | 2.20M |
| Net Income | 244.60M | 145.50M | 103.90M | 60.60M | 70.30M | 98.90M | 105.00M | 136.30M | 66.90M | 108.20M | 118.00M | 117.70M | 195.10M | 80.80M | 55.00M | -720.50M | -13.70M | -150.60M | -46.80M | -854.10M | -265.80M | -445.20M | -39.80M | 206.68M | 68.40M | -48.50M | -6.90M |
| Net Income Ratio | 3.07% | 2.01% | 1.84% | 1.05% | 1.19% | 1.49% | 1.72% | 2.27% | 1.19% | 1.92% | 2.04% | 1.81% | 2.70% | 1.24% | 0.90% | -9.38% | -0.17% | -1.71% | -0.55% | -9.66% | -3.95% | -5.38% | -0.40% | 2.12% | 1.29% | -1.49% | -0.34% |
| EPS | 2.04 | 1.13 | 0.81 | 0.49 | 0.55 | 0.71 | 0.74 | 0.98 | 0.43 | 0.61 | 0.64 | 0.56 | 0.89 | 0.44 | 0.24 | -3.14 | -0.06 | -0.66 | -0.21 | -3.85 | -1.23 | -1.94 | -0.19 | 1.01 | 0.41 | -0.26 | -0.05 |
| EPS Diluted | 2.03 | 1.13 | 0.81 | 0.49 | 0.55 | 0.70 | 0.73 | 0.96 | 0.42 | 0.60 | 0.64 | 0.56 | 0.88 | 0.44 | 0.24 | -3.14 | -0.06 | -0.66 | -0.21 | -3.85 | -1.23 | -1.94 | -0.19 | 0.99 | 0.40 | -0.26 | -0.05 |
| Weighted Avg Shares Out | 120.10M | 123.50M | 126.70M | 129.10M | 131.00M | 139.40M | 143.10M | 141.80M | 155.80M | 178.40M | 183.40M | 208.60M | 216.30M | 227.80M | 229.50M | 229.30M | 228.90M | 227.20M | 226.20M | 222.10M | 216.83M | 229.80M | 213.90M | 199.79M | 167.20M | 183.02M | 132.00M |
| Weighted Avg Shares Out (Dil) | 120.30M | 123.60M | 126.70M | 129.10M | 131.80M | 140.60M | 145.20M | 143.90M | 157.90M | 180.40M | 185.40M | 210.50M | 218.30M | 230.10M | 230.90M | 229.30M | 228.90M | 227.20M | 226.20M | 222.10M | 216.83M | 229.80M | 213.90M | 217.91M | 178.43M | 183.02M | 132.00M |
Why Celestica Stock Is A Strong Buy Into Q3 Earnings
Celestica is expected to beat both revenue and earnings, driven by strong AI demand and favorable market conditions. Management's guidance and analysts' expectations suggest significant growth, with my estimates being even higher, particularly in the AI-driven CCS segment. The company...
Why Celestica Stock Is A Solid 'Buy' Before Q3 Earnings Release
I still believe that Celestica is one of the most undervalued and underlooked opportunities in the AI market today. The company's Q2 FY2024 results showed impressive year-on-year growth, with sales up 23% and EPS up 65.45%, indicating effective operating leverage....
Celestica: Still A Value Buy Despite The Recent Recovery
CLS' overly expensive valuations have finally been brought closer to earth, thanks to the recent market rotation in July/ August 2024. With the two main players in AI still reporting robust performance metrics, we believe that CLS remains a compelling...
Wall Street Analysts See Celestica (CLS) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do...
Celestica Launches the DS4100, its Latest 800G Switch Optimized for AI/ML Data Center Workloads
TORONTO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Celestica Inc . (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world's most innovative companies, today launched its DS4100, a new 1U 800G per...
Celestica (CLS) Shares Surge with Strong Institutional Support
Celestica Inc. (CLS, Financial) saw a significant stock price increase of 5.01%. The stock is currently trading at $58.50 per share with a trading volume of 1.23 million shares, a turnover rate of 1.04%, and a price fluctuation of 4.58%.
Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes
- Maintained Stable Visual Acuity and Anatomical Control Over 9 Months - - Positive Safety Profile with No Ocular or Treatment-Related Serious Adverse Events - - 67% of CLS-AX Participants Did Not Require Any Additional Treatment up to 6 Months...
This Growth Stock Is Powering Toward A Buy Point As Its Relative Strength Rises
Celestica stock is working on a five-day winning streak as it approaches its all-time high, which is also its buy point.
Celestica, Inc. (CLS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Celestica (CLS). This makes it worthwhile to examine what the stock has in store.
Celestica to Hold Q3 2024 Financial Results Conference Call and Virtual Investor Meeting Wednesday, October 23, 2024
TORONTO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Celestica's third quarter financial results conference call and virtual investor meeting will take place on Wednesday, October 23. The conference call start time is 5:00pm ET. Financial results will be released after market...
Source: https://incomestatements.info
Category: Stock Reports